Preamble
e present guideline updates and summarizes S1-and S2-guidelines published by the German Association of Scienti c Medical Societies (Arbeitsgemeinscha der Wissenscha lichen Medizin ischen Fachgesellscha en, AWMF) which have been published on various aspects of food allergy [1, 2, 3, 4, 5, 6, 7] .
It ful lls the methodological requirements set out by the AWMF on the development of guidelines for diagnosis and treatment and represent S2k-guidelines according to the AWMF three-level concept. DELBI criteria were taken into account [9] .
e strength of recommendation for the individual recommendations is expressed in the guidelines using standardized formulations (Tab. 1) [10] .
e guideline is based on the current European Academy of Allergy and Clinical Immunology (EAACI) S3-guideline on the diagnosis and treatment of food allergy [11] , as well as on systematic EAACI reviews [12, 13] from 2014, for which systematic literature searches of PubMed, meta-analyses, clinical studies, and other scienti c investigations were undertaken. Consensus on the present guideline was achieved independently from the European guidelines by an interdisciplinary panel of German-speaking experts who were nominated by the participating societies.
Epidemiology and the most common food allergy triggers
How are food allergies di erentiated on the basis of their sensitization pathway? How common are food allergies? What are the risk factors for food allergy? What is the prognosis of a food allergy? What are the most common food allergies? -Primary food allergies primarily occur as a result (most likely) of gastrointestinal sensitization to predominantly stable food allergens (glycoproteins). -A secondary food allergy develops a er primary sensitization to airborne allergens (e. g., pollen allergens) with subsequent reactions (due to crossreactivity) to structurally related o en labile allergens in (plant) foods.
Prevalence of food allergies
e prevalence of food allergies varies from region to region and has risen in some countries in recent years.
us, the prevalence of peanut and tree nut allergy increased three-fold in the US over the last decade. A food allergy results in a reduction in the quality of life of a ected individuals and can follow a lethal course in rare cases [15] . In order to assess the: -incidence, -prevalence, -current developments, -potential risks and -prognostic factors ... of food allergy in Europe, studies aimed at answering these questions and published in the period between 2000 and 2012 were evaluated in a meta-analysis [16] . e point prevalence of self-reported food allergy was approximately six times higher compared with food allergy tested using oral food challenge. e prevalence of primary food allergy was higher in children compared with adults. On the other hand the increased prevalence of secondary food allergies due to cross reactions with inhalation allergens can also be attributed to an increased awareness and improved diagnosis in recent years.
Only a few studies on the epidemiology of food allergies in Germany are available. A study from 2004 revealed a prevalence of food allergy of 3.7 % in adults [17] and 4.2 % in children [18] by double-blind, placebo-controlled oral food challenge. A recent study on adult health in Germany (DGES) conducted between 2008 and 2012 revealed a lifetime prevalence of food allergy of 6.4 % in women, 2.9 % in men and as 4.7 % for the entire adult cohort (95 % con dence interval, 4.1-5.4) [19] . Prevalence of food allergy in Germany: -Suspected: ~20 % -Con rmed by oral food challenge (2004): -Children: 4.2 % -Adults: 3.7 %
Risk Factors
At present, there are no consistent risk or prognostic factors for the development or outcome of food allergy. However, the following factors in uence the prevalence of food allergy: -sex and age -Place of residence/geographic location -Family history of atopy -Concomitant allergic diseases From a geographical perspective, the highest prevalence of food allergy in children compared with adults was in North-West Europe. A lower prevalence of self-reported and con rmed food allergy was found in Southern Europe. e authors of the meta-analysis recommend that data on the prevalence of food allergy should be interpreted with caution due to the heterogeneity of the studies and/or methodological or diagnostic di erences within one, and between (di erent) geographical regions of Europe. e prevalence of food allergy is challenging to determine for a variety of reasons: -presence of augmentation factors (factors that promote the onset of food allergy symptoms) -lack of reproducibility of convincingly described symptoms -presence of hidden foodstu s and of novel foods -insu cient knowledge of threshold values -inadequate consideration of individual sensitization pro les -natural tolerance development and new onset of allergies at di erent ages in life
Prognosis
Data on the course of food allergies show that milk protein allergy in early childhood has a good prognosis for the spontaneous tolerance development, while peanut and tree nut allergies tend to persist into adulthood. Further studies are required in the future to de ne the long-term prognosis of food allergy.
Primary triggers of food allergies according
to age e most frequent triggers of food allergy in children and adolescents include: milk and hen's egg, soy, wheat, peanut and tree nuts. In adults pollen-associated food allergy is more prevalent and mostly induced by apple and other pome and stone fruits, including shell fruits (see also Tab. 6), vegetables (celery, carrots), and shell sh. e pro le of food all ergens that trigger severe allergic reactions is shown in Fig. 1 .
Core statements
Food allergy prevalence is age-dependent. A study on food allergy prevalence in Germany shows a prevalence of 4.2% in children and 3.7% in adults. strong consensus IgE-mediated food allergies are differentiated into primary (predominantly in early childhood) and secondary (predominantly pollen-related) allergies, which follow courses of varying severity.
consensus Food allergies can significantly reduce the quality of life and may be lethal in rare cases. consensus Worm, Jappe
Food allergy prevention
Which measures are capable of in uencing/reducing the occurrence of a food allergy? e goal of primary prevention is to reduce the risk of allergic sensitization and allergic disease. To achieve this, causal or predisposing factors are either altered or an individual's tolerance raised. In terms of the prevention of allergic diseases, a small number of recommendations apply exclusively to high-risk individuals whose father, mother, and/or
Tab. 1: Strengths of recommendation

Strength of recommendation Syntax
Strong recommendation Shall
Recommendation Should
Open recommendation Can siblings are already a ected by allergic disease. Most recommendations are also appropriate for non-high-risk individuals. e German evidence-and consensus-based S3-guideline on allergy prevention in Germany from 2004 was updated in 2009 [21] and 2014 [22] . e recommendations cover following guideline areas: a) breastfeeding b) mother and child nutrition, c) exposure to inhalation allergens or indoor and outdoor air pollutants, including tobacco smoke, d) keeping animals, e) vaccinations and f) mode of delivery in childbirth. -ere is evidence that the consumption of fruit and vegetables (a so-called Mediterranean diet), ω-3-fatty acids (FA) (or a good ω-3:ω-6 ratio), and milk fat has a preventive e ect on atopic diseases. -Probiotics have only been shown to have a preventive e ect on atopic dermatitis. Due to the he- 
CI, confidence interval
Guideline Guidelines on the management of IgE-mediated food allergies terogeneity of bacterial strains used and study designs applied, it is not possible to make recommendations on speci c preparations, modes of administration, or duration and time of use. -As yet, prebiotics have only been shown to have a preventive e ect on atopic dermatitis. Due to the small number and heterogeneity of studies, no recommendations can be made. -Associations described between the use of antibiotics, paracetamol, or acetaminophen and atopic disease cannot be reliably interpreted and no causal link has been found between the use of these pharmaceutical drugs and the development of atopic disease(s). -ere is evidence that adverse psychosocial factors (e. g., stressful life events) during pregnancy and childhood can contribute to the onset of atopic disease. In addition to the S3-guideline, there is evidence that the use of antacids can promote the risk of sensitization and increase the severity of food allergy [23] . Although the immune system is most commonly exposed to food proteins via oral/gastrointestinal routes, exposure can also take place via the following routes: -Percutaneous (via the skin, e. g., contact urticaria) -Inhalation (via the respiratory tract, e.g., baker's asthma, see Sect. 7 below) -Parenteral (via the vascular system, e. g., contamination of injection solutions with food proteins). e exposure route is relevant in terms of clinical symptoms. A variety of symptoms -o en in combination -can be observed depending on the organ system a ected (modi ed according to [26] Tab. 4 provides an overview of food allergy manifestations and di erential diagnoses.
Non-allergic mechanisms:
Food additives and natural avorings can also potentially activate mast cells and imitate clinical symptoms of an IgE-mediated food allergy: for example, G-protein-coupled receptor activation, changes in eicosanoid metabolism, and increased mediator production/expression have been postulated. Isolated cases of non-allergic food intolerance reactions triggered by natural avorings, sulfur compounds, benzoic acid compounds, histamine-containing foods, and glutamate have been described. Augmentation factors may be necessary to elicit a reaction, thus these should be considered where oral challenge is negative.
It is unlikely that salicylate-containing foods are of any relevance in acetylsalicylic acid (ASA) intolerance, since salicylic acid is not commonly found in foods [28] ; however, this has not been su ciently researched.
Core statements
In the case of suspected food allergy, it is important to consider in the differential diagnosis chronic inflammatory diseases, carbohydrate malabsorption and functional or somatoform disorders. strong consensus Depending on patient symptoms and age, other diseases need to be taken into consideration in the differential diagnosis of suspected food allergy. strong consensus A (pediatric) gastroenterologist should be involved in the diagnostic work-up in the case of suspected non-IgE-mediated gastrointestinal intolerance reactions. 
Food allergy diagnosis
How can one reliably diagnose a food allergy?
Approach in suspected food allergy: In suspected IgE-mediated food allergy, diagnosis is based on a number of components ( Fig. 2) (Fig. 2) . Results are not always consistent; in such cases, a positive result is more likely to be correct than a (false) negative result. Consistent results (concordant positive or negative) increase diagnostic accuracy, particularly if mostly di erent food reagents (native preparation, extracts, single allergens) are used in skin or IgE tests.
Test interpretation: e patient history is of central importance in the interpretation of sensitization tests: A food allergy can only be diagnosed or excluded in the case of clear concordance between clinical patient information and test results (skin prick test/ IgE determination). In the case of absent or insucient concordance (e. g., due to unclear or inadequate patient history), clinical relevance should be investigated using oral challenge ( Fig. 2 
Patient history and diet/symptom protocols
How important is the history of patients in suspected food allergy? Which aspects of the patient history need to be considered in suspected food allergy? 4.1.1. Practical approach to history-taking Allergy history-taking in suspected food allergy follows the general principles of interviewing. Providing patients with a special questionnaire prior to their initial appointment is helpful; patients should either bring the completed questionnaire to their appointment or complete it in the waiting room. History-taking (Tab. 5) includes family history, personal history and speci c dietary history. e times, places, and situations in which reported symptoms occur should be recorded. It is particularly important to establish whether the patient experiences periods of complete freedom from symptoms.
Supporting measures
A diet-and symptom diary helps patients to observe their habits and symptoms. Particularly if symptoms are permanently apparent, it is helpful for patients or their parents to keep a record over a period of 2-3 weeks Besides the intake of food, but also beverages, confectionery, chewing gum, etc., symptoms occurring in temporal relationship to this intake should be recorded. Recordings are evaluated by a dietician with experience in allergy, or an allergist.
Drug use should also be recorded in the diary. Symptoms should cover the type and intensity and date, time, duration it present and particular features (e. g., restaurant food). Once a diagnosis has been made, the further diagnostic and therapeutic approach is planned with the help of a follow-up patient history. In this way it is possible to qualify or con rm the relevance of existing (or absent) sensitizations and facilitate the decision-making process on challenge testing or other measures. It is also important to bear in mind that some medications [e. g., proton pump inhibitors (PPI) or alkylating drugs) can promote the development of sensitization [29] .
Consideration of augmentation factors
Augmentation factors should also be taken into consideration in the patient history. ese can magnify an allergic reaction and, in some cases, need to be present in order to facilitate the onset of symptoms occur (e. g., in wheat-dependent exercise-induced anaphylaxis). e most widely known augmentation factors include: -physical activity and -the use of non-steroidal anti-in ammatory drugs (NSAID) Moreover, alcohol, pyrexia, acute infections and allergic symptoms during the pollen season have also been described as augmentation factors [30] . [32] . e diagnostic suitability is evaluated separately according to the allergen source and test procedure.
Recommendations
Indication for IgE determination
ere are a number of di erent indications for in vitro diagnosis [33] depending on: -age, -symptoms and -suspected allergen source (Tab. 6).
Suspicion/exclusion of a food allergy: Specific IgE determination is helpful if food allergy is suspected or should be excluded. This indication requires that the allergen sources or allergens used in the test are fully represented and are capable to detect potentially present IgE antibodies.
Panel tests for speci c IgE (e. g., to peanut, sh, chicken protein, cow milk protein, soy, and wheat) make it possible to reasonably exclude as as basis for further or detect sensitization. us, they serve as a for a further detailed breakdown of single allergen sources. Broad screening panels in the absence of a reasonable suspicion of food allergy are not recommended.
Severe allergic reactions to foods:
Determining specific IgE to the foodstuff suspected (or to be excluded) in severe anaphylactic reactions is preferred and skin testing should be performed after consideration of the individual risk:benefit ratio.
Suspected sensitization to foods suitable for skin testing: Speci c IgE determination is recommended in such cases where skin testing is not suitable to detect sensitization (e. g., skin-irritating foods such as spices).
Conditions that preclude skin testing or its interpretation: Speci c IgE determinations are helpful if skin testing is not suitable. Such cases involve urticaria factilia or active skin disease in the test area in a given Patient or the use of drugs that a ect skin testing. Analysis of speci c serum IgE to allergenic foods is o en determined in infants and young children instead of performing skin tests.
Common food allergen sources with low potential risk:
Mild clinical reactions (e. g., oropharyngeal symptoms in pollen-associated food allergy) can be tested in the usual diagnostic work up, i. e., patients history, skin testing, in vitro diagnosis. Sensitizations in birch pollen-associated food allergy should be tested by native prick-to-prick testing, since commercially available extracts do not contain the relevant allergens su ciently. Screening (including serological tests) without speci c suspicion of food allergy, e. g., of all fruit and vegetable types or the available single allergens in birch pollen-associated cross-sensitization, is not recommended [3] . A lower LoQ when using single allergens in IgE diagnostics does not necessarily increase diagnostic sensitivity. Where this is the case diagnostic speci city can be lower. (Tab. 11).
Tab. 6: Important allergen sources in childhood and adult food allergies
Both parameters, diagnostic sensitivity and specificity, can result in difficulties regarding the interpretation of specific IgE diagnostic methods: A positive IgE finding, reflecting sensitization without information on previous history, cannot per se predict clinical reactions in food allergie individuals. Therefore , international guidelines on allergen-specific IgE test methods [38] no longer require diagnostic sensitivity and specificity to be given, but are replaced by analytical parameters. Thus, the use of single allergens for IgE determination is justified, most notably by their greater test sensitivity (lower LoQ) and analytical specificity: Where single allergens are capable of improving in vitro diagnosis, their use is helpful and recommended from an allergological perspective.
Tab. 7: List of de nitions and abbreviations
Allergen
A molecule (protein, e. g., major allergen Gad c 1 from cod, more rarely a carbohydrate component) that elicits an allergic immune response
Allergen extract A mixture of allergenic and non-allergenic components extracted from an allergen source (e.g., fish allergen extract)
Origin/source material of the allergens (e.g., fish)
α-Gal Galactose-α-1,3-galactose, a disaccharide as the cause of severe anaphylaxis to mammalian meat, gelatin, and biologicals Ara h 2 2S albumin, a peanut storage protein associated with severe systemic reactions in peanut allergy 
Foodstu s as allergen sources and their allergens
Foodstu s are complex allergen sources and contain a variety of (glyco)proteins, the actual allergens. A relationship is therefore formed by the biological taxonomy of the foodstu s in question and via biochemical similarity of the allergens contained. e relevance of allergen sources (Tab. 6) is related to the age of the a ected patient and depends on regional and personal dietary habits.
Important plant protein families and their allergens
Fruit, vegetables, legumes, tree nuts, oilseeds, and cereal contain allergens and can cause sensitization [39] . Pro lins: From a phylogenetic perspective, pro lins are strongly conserved proteins and are considered to be clinically less relevant allergens. Sensitizations are, o en caused primarily by grass-pollen exposure but, are potentially linked to all pollen and numerous plant foods (e. g., apple, carrot) due to cross reactions. Determination of sIgE against one prolin (e. g., grass pollen pro lin Phl p 12, birch pollen pro lin Bet v 2, or peach pro lin Pru p 4) is usually su cient for diagnostic purposes. Exotic fruits not belonging to the Bet-v-1 food allergen cluster (e. g., melon, banana, avocado, mango) have been reported to induce oropharyngeal symptoms [3] .
Bet v 1-homologous PR-10 proteins:
Birch pollen allergy in Central Europe is predominantly due to sensitization to the major allergen Bet v 1, a natural plant stress protein (pathogenesis-related protein family 10, PR-10).
Similar PR-10 proteins are found in hazel, alder, beech, and oak tree pollen, but also in various types of fruit and vegetables, as well as nuts and legumes (Tab. 8). ey form the basis for birch pollen-asso- ciated cross reactions, e.g., to apple, cherry, peach, and hazelnut, among many others [3] . Due to the low proportion of PR-10 proteins in the total mass and their lack of heat and digestive resistance, symptoms are caused only by raw foods and generally remain restricted to the mouth and throat. In individual cases, severe systemic symptoms may occur, e.g., if large quantities of the food are consumed or due to matrix e ects (the PR-10 protein is protected by other food components) (examples: Gly m 4 in soy, more rarely also Api g 1 in celery, Dau c 1 in carrots).
Lipid transfer proteins:
Systemic reactions induced by fruit, vegetables, nuts, legumes, and cereals can be caused by LTP. Ripe peach can initiate primary sensitization, as described in the Mediterranean region. e structural similarity of peach LTP, Pru p 3, to other heat-and acid-stable LTP can cause cross reactions to other plant foods and to a certain extent independent from the Bet v 1 cluster described (e. g., wine grapes, blueberries, vegetables). e major allergen Pru p 3 is o en sucient to detect sensitization. e clinical relevance of LTP sensitization in terms of plant foods to be avoided in the future needs to be established with the patient on a case-by-case basis. is is achieved on the basis of the patient's previous history (clinical reaction) or, in cases of doubt, oral challenge with the suspected LTP-containing foods.
Seed storage proteins: Storage proteins are structurally related yet variable, stable and clinically relevant food allergens, e. g., in nuts, seeds, legumes, including peanut, soybean, lupin, and cereals. A distinction is made between 2S albumins from the prolamin and globulins from the cupin superfamilies on the basis of their structure. e globulins contain vicilins (7S globulins) and legumins (11S globulins) (Tab. 8). Due to their stable structure and high proportion of the total protein, storage proteins rarely cause problems in extract-based diagnosis. ey are associated with an increased risk for systemic symptoms due to their heat and digestive stability. e following storage proteins are well suited for a selective detection/exclusion of sensitization by analytical methods: -Gly m 5 and 6 in soy allergy -Ara h 1, 2, 3, and 6 in peanut allergy -Cor a 9 and 14 in hazelnut allergy -Jug r 1 and 2 in walnut allergy -Ber e 1 in Brazil nut allergy Serological cross reactions between storage proteins do not permit predictions of the onset of clini cal symptoms.
Other allergens in plant derived foods
Cross-reactive carbohydrate epitopes: Numerous plant derived foods are glycoproteins containing CCD (Cross-reactive Carbohydrate Determinants) (e. g., in pollen, plant foods, articulates, molluscs, and certain pathogenic helminths). Oleosins: Oleosins are allergens which are present in high fat plant foods. As lipophilic proteins, they are underrepresented in aqueous extracts of legumes (e. g., peanut), seeds (e. g., sesame), and tree nuts (e. g., hazelnut) ey can results in false-negative dia gnostic results. In such settings, testing of the native foodstu in skin tests is suggested.
Thaumatins and enzymes:
aumatin-related proteins are thermo-and digestion-stable plant foods [40] , i. e. from cherry (Pru av 2), apple (Mal d 2), kiwi (Act d 2), banana (Mus a 4), peach (Pru p 2), tomato, bell pepper and walnut. ey are rarely available for diagnostics (Act d 2 from kiwi, ImmunoCAP ISAC®). e prevalence of sensitizations or clinically relevant reactions is unknown. A similar situation is present for a number of enzymes found in plant foods (e. g., exo tic fruits).
Common animal food allergens
Animal proteins from a variety of allergen sources can also induce food sensitization. ese are o en heat-and digestion-stable and can cause systemic allergic reactions.
eir structural similarity induces serological cross reactions within a protein family. However the clinical relevance cannot be deduced from the test result. Due to complex sensitization patterns and good representation of the proteins, diagnosis using extracts is o en su cient.
Hen's egg: e most important hen´s egg allergens have been identi ed (Gal d 1, 2, 3, 4) .
Sensitizations to the heat resistant major allergen Gal d 1 are frequently associated with persistent hen's egg allergy. e failure to detect IgE during the course of hen's egg allergy can indicate the development of tolerance. Despite clinically relevant hen's egg allergy (also in Gal d 1 sensitization), the majority of a ected patients tolerate egg in cooked form.
Cow's milk:
Complex sensitization patterns to predominantly stable cow milk proteins and the fact that these proteins are well represented in cow milk extracts are rationales to use the total extract for dia gnostic purposes. Due to their stability, some single allergens, such as Bos d 8 (casein), are associated with persistent cow's milk allergy and reactions to processed milk (products). Decreasing or absent IgE may indicate the development of tolerance. Again, the majority of cow's milk allergics tolerate cow's milk in cooked form.
Meat: Allergies to mammalian meat, particularly a er consumption of pluck, can be caused by sensitization to serum albumins. Due to high cross reactivity, determining IgE to one representative serum albu min (e. g., Fel d 2 from cat, Bos d 6 from cow) is su cient.
A further source of allergic reactions following the consumption of meat is a carbohydrate epitope (CCD) found in mammals (but not primates): α-Gal.
is carbohydrate side chain is responsible for delayed urticarial and severe anaphylactic reactions following the intake of red meat [42] ; poultry, on the other hand, is tolerated. In suspected meat allergy, IgE determinations to albumins, α-Gal (o215, ImmunoCAP®, ermoFisher), and the suspected meat type are helpful. cause sensitization, extract-based diagnosis with the suspected sh type is recommended. e high stability of most sh allergens to heat and digestion, as well as the fact that they make up a large proportion of the total protein, explains their hazardous nature: Even small amounts can be su cient to trigger systemic reactions.
Crustaceans and molluscs: Tropomyosin, a muscle protein with high cross reactivity, is considered an important major allergen in crustaceans and shellsh. In addition to determining this major allergen (e. g., Pen a 1, shrimp tropomyosin), the use of extracts from the suspected animal is recommended due to additional possible allergens. Shrimp can also trigger exercise-induced anaphylaxis. House dust mite allergy su erers sensitized to tropomyosin, minor allergen Der p/f 10, can react to crustaceans. 
Cellular techniques to detect IgEdependent sensitization
IgE-mediated sensitization can also be detected indirectly using a basophil activation test (BAT). These tests are complex, costly, and only helpful in in vitro diagnosis in individual cases of suspected food allergy (e. g., in unusually low total IgE, < 20 < 10, < 5 kU/l). 14) .
Core statements/recommendations
In practice, skin testing with pollen extracts is helpful in the case of suspected pollen-associated food allergy. Commercial solutions can be used for those foods that have been shown in studies to have high test sensitivity and diagnostic sensitivity in food allergy diagnosis, such as sh extract. In the case of fruit, vegetables and meat, prick-to-prick testing using native foodstu s is considered more sensitive. erefore these are more diagnostically sensitive, however less speci c.
Advantages and disadvantages of testing with native material
Skin testing with native material can be helpful if original recipes are tested. A skin test, e. g., with a cooked, mixed original recipe, allows to assess whether the possible individual components should be investigated. Furthermore, skin testing o ers to test the processed foodstu s in a given meal and to assess any possible alterations to their allergenicity.
One drawback of skin testing with native material is in its lower diagnostic speci city. us, one may obtain e. g. false-positive results due to the irritant potential of native foodstu s. In rare cases, native foodstu s used for skin testing can cause 
Other skin testing methods and their diagnostic value
Intracutaneous tests using foods are not relevant in practice, since they bear a considerably higher risk of systemic reactions and may lead to false-positive reactions. Atopy patch tests using fresh foods, e. g., based on the suspicion that atopic eczema may be aggravated by food allergens, only rarely yield helpful additional information. Greater emphasis will be placed on the use of fresh foods in skin testing in the future, since the number of commercially available extracts declines as these today need to be approved as medicinal products according to European legislation. Due to the high costs associated with this procedure manufacturers will only o er the most demanded allergen sources [2, 3, 44] .
Recommendations/core statements
The skin prick test is the preferred skin testing method in the diagnostic work up of IgEmediated food allergy. 
Diagnostic elimination diet and challenge testing
What is a diagnostic elimination diet and for how long should it be performed? How important is food allergen challenge testing and how should it be performed?
Elimination diets
A diagnostic elimination diet comprises the controlled avoidance of foods for a certain period of time. In cases of chronic disease such as atopic dermatitis, the diet should not last longer than 1 to maximally 2 weeks, except in exceptional cases. Longer times (3-4 weeks) may be required for non-IgE-mediated reactions. ere is evidence to suggest that long-term elimination in IgE-mediated food allergy increases the risk of immediate reactions upon reintroduction of relevant foods. It should therefore be avoided. A diagnosis can be supported or excluded by evaluating detailed (complete) documentation in the form of a diet and asymptom diary. is approach avoids unnecessary food restrictions.
Oral food challenge should be performed under medical supervision following a diagnostic elimination diet.
e extent of dietary measures needs to be reviewed if no symptom improvement is seen under diagnostic food avoidance. In such cases, either symptoms are non-food-related or not all potential triggers have been identi ed and hence eliminated, or augmentation factors are a ecting reactivity.
Use of therapeutic infant formula during the diagnostic process
Non-breastfed infants with suspected cow's milk allergy require a cow's milk substitute in the form of an extensively hydrolyzed infant formula or an amino acid-based formula during the period of diagnostic elimination; formulas should be selected on a case-by-case basis (see also Sect. 5.3). Allergy to the avoided food is highly unlikely if symptoms fail to improve despite a carefully controlled elimination diet. In such cases, the food in question should be reintroduced into the infant's diet in order to ensure a varied diet and to avoid unnecessary dietary restrictions.
Oral food challenges
In general, controlled oral challenge testing is required for the diagnosis of a food allergy or to prove clinical tolerance (Tab. 15). Furthermore, it has been repeatedly shown that patient quality of life improves irrespective of the outcome of oral food challenge testing.
e procedure for food challenge testing has been described in detail in national (GPA-Manual: https://www.gpau.de/ leadmin/user_upload/GPA/dateien_indiziert/ Stellungnahmen/Manual_NMA_2009.pdf) and international guidelines (EAACI, PRACTALL consensus paper). e "food allergy due to immunological cross reactivity with inhalant allergens" guideline [3] describes the particular features of challenge testing in pollen-associated food allergy in greater detail.
Decision-making criteria and in uencing factors
e recommendations include diverse variables that need to be taken into consideration in order to be able to perform challenge tests tailored to the individual patient: is test format should also be performed in the case of subjective, delayed or atypical symptoms or if patients (or parents) are anxious. Furthermore, it is required to use DBPCFC in scienti c investigations, e. g., to establish the clinical relevance or potency of certain allergens, but also if a threshold dose for de ned food allergen is determined. e food should be administered in "blinded" form in terms of: -Taste -Aroma -Texture -Administration form (consistency, color and form) Placebo and verum should be indistinguishable from each other.
In order to avoid severe reactions, patients receive the food to be tested in a titrated manner, generally in semi-logarithmic increments at time intervals of 20-30 min. Quantities between 3 mg and 3 g -based on the protein content of the administered foodhave proven to be su cient for many foodstu s such as cow's milk, hen's egg, peanut and tree nuts.
Food challenges are generally discontinued as soon as a clinically detectable reaction occurs, or are ended if the nal dose administered, as well as repetitive administration of the cumulative total dose (e. g., the following day) is tolerated without clinical symptoms. If subjective symptoms occur, the subsequent dose should be exposed or the previous dose repeated. Immediate-type reactions generally occur within 2 h of the last food intake. Since atopic dermatitis may worsen several hours (or Food challenge meal preparation The food challenge meal should contain, as realistically as possible, the usual edible form of the food that elicits the reaction. Processing a food, as well as its incorporation in a matrix, can significantly affect its allergenicity (e.g., raw vs. cooked egg). Fresh fruit and vegetables should preferably be used in challenge testing to confirm pollenassociated food allergy, since triggering proteins are generally heat-labile.
Matrix selection Careful attention should be paid to ensure that no other allergens to which the patient reacts are included in the meal.
As few ingredients as possible should be used. Placebo meals should resemble the sensory characteristics of the test food as closely as possible.
Dosage Number of doses
In most cases, titration in seven semi-logarithmic steps should be selected. A single dose may be adequate if negative challenge is expected and there are no safety concerns
Initial dose
In clinical routine, an initial dose of 3 mg food protein is generally appropriate for most foods. Lower doses should used for threshold dose challenges and high-risk patients.
Maximum dose
Corresponding to an age-adjusted portion, 3 g food protein is appropriate for most foods.
Cumulative total dose
A cumulative total dose should be administered the following day or on another day, since some patients react only upon repeated administration.
Time interval between doses 20-30 min, but should be adjusted according to previous history even over the course of the following day) a er food challenge, it is necessary to perform a skin examination on the following day. Although urticaria and/or angioedema are the most common immediate-type reactions, gastrointestinal, respiratory and cardiovascular symptoms may occur and patients require to be medically supervised upon provocation.
Safety aspects
For reasons of safety, oral challenges should only be performed in a setting where allergic reactions, including anaphylaxis, can be treated adequately and in an age-appropriate manner. Personnel should be trained and experienced in early recognition of symptoms and emergency management. Age-and weight-appropriate emergency medication that may potentially be required should be noted, e. g., in the patient's le prior to the challenge test and kept ready to use. In the case of non-IgE-mediated reactions, challenges should be tailored to the individual requirements of the patient.
Core statements
Oral food challenge (in particular DBPCFC) is the gold standard for the diagnosis of IgEmediated food allergies.
strong consensus
Augmentation factors should be taken into consideration in challenge tests. strong consensus Food challenges should be performed to confirm or exclude allergy.
Food challenges built the basis to safely determine the patient's range of tolerated food and enables counseling on appropriate allergen avoidance and risk assessment for severe reactions (anaphylaxis).
consensus A negative oral challenge should be followedup by a repeated administration on the following day at the earliest of the tested food in a quantity adjusted to age-and everyday eating habits. Most primary IgE-mediated food allergies take the following course:
Onset in infancy or early childhood and spontaneous remission either by school age or adolescence [26] depending on the food and comorbidities [54] / cofactors.
Although rare, later onset at school age or adulthood is possible.
e natural course depends on the food source: cow's milk [55] , hen's egg [56, 57] , wheat [58] , and soy allergies [59] tend to develop into spontaneous remission during the rst years of life. Peanut [60, 61, 62, 63, 64] , tree nut [65] , but also sh and crab allergies [66] , o en persist. High speci c IgE titers frequently correlate with clinical relevance and are less likely to develop into clinical tolerance. Speci c IgE antibodies to food are o en found as early on as in infancy and early childhood. Values can rise or fall later on. A decrease may be associated with tolerance development. ere is evidence to suggest that the natural course of food allergy alters, resulting in slower tolerance development [25, 54, 67] . Recent data, primarily from the US, indicate that low speci c IgE antibodies, low skin prick test diameter and mild atopic eczema tend to be associated more frequently with food allergy remission [25] .
Food allergies in adulthood can represent either a persistent childhood form or a de novo sensitisation. Major triggers of food allergy in adulthood according to frequency are apple, peanut, kiwi, hazelnut, peach, cow's milk, hen's egg, wheat, sh, and shrimp [68] . Cross reactivity due to speci c IgE to inhalant allergens are more frequent compared with primary food allergies -particularly in the form of birch pollen-associated food allergies in German-speaking countries (see Sect. 4.2). ese adult-onset food allergies may persist [69] .
Recommendations
Due to the natural course of cow's milk, hen's egg, wheat and soy allergy in children, oral food challenges should be repeated at regular intervals (e.g., every 6, 12 or 24 months) to assess for tolerance development.
strong consensus
Provocation testing should be performed at longer intervals (e.g., every 5 years) in children with peanut and primary tree nut allergy, as well as fish and oilseed allergy. 
Treatment of IgE-mediated food allergies
Food allergy treatment is based on: a) Short-term management of acute reactions b) Long-term strategies to reduce the risk of further reactions e latter include dietary treatment and training programs. Training programs are designed to help a ected individuals to avoid allergens and to learn how to react upon accidental allergen contact (e. g., use of emergency medicine). Sublingual or oral im-munotherapy appear to o er new perspectives to achieve clinical tolerance.
Treatment of acute reactions
Assessing the risk of potentially severe reactions is an essential part of successfully caring for food allergy patients. is risk varies according to subgroup. us, patients with -previous anaphylactic reactions, -severe and/or uncontrolled bronchial asthmaor -speci c underlying diseases (mastocytosis) are at greater risk.
e "Anaphylaxis" guidelines describe how to recognize and to treat anaphylactic reactions. In addition to emergency medical measures (e. g., administering uids and oxygen, monitoring circulation, ABCD measures), emergency medication should be administered immediately. ese are de ned as immediate-action rst-aid medications aimed at preventing the pathophysiological e ects of anaphylaxis.
ey include adrenaline, bronchodilators, antihistamines and glucocorticosteroids [70] . Intramuscular administration of adrenaline is the rst-line treatment in anaphylaxis [20] .
A systematic overview of EAACI guidelines on the treatment of food allergies revealed only weak evidence for the e cacy of H1 antihistamines. is nding relates to three randomized and two non-randomized comparative studies in children and adults with acute non-life-threatening symptoms caused by food allergy [71] .
ere is no evidence to suggest that antihistamines are e ective against respiratory or cardiovascular symptoms. However, the prophylactic use of antihistamines can mask early symptoms of anaphylaxis, thereby delaying the requisite use of adrenaline [70] .
According to the guideline on the acute treatment of anaphylaxis [70] , glucocorticosteroids also belong, alongside adrenaline and antihistamines, to the arsenal of acute treatments for food-related allergies, although there are no systematic clinical studies on this indication [72, 73, 74] . A nonspeci c membrane-stabilizing e ect following high-dose administration (500-1000 mg methylprednisolone) has been postulated in reviews. However, they are also e ective at intermediate doses (1-2 mg/kg methylprednisolone) in the treatment of asthma and act against prolonged or biphasic reactions. All medical practice should have acute medication available.
(Long-term) Drug treatment of food allergy
Studies on the prophylactic use of mast cell stabilizers have yielded varying clinical results [77] . Four randomized studies and two non-randomized comparative studies showed that mast cell stabilizers are able to reduce symptoms, while three randomized studies found no e ect. us, it is currently not possible to make a standard recommendation on the use of mast cell stabilizers; instead, a di erentiated approach depending on the patient cohort investigated is required.
-e mode of action of mast cell stabilizers, such as cromoglicic acid or ketotifen, is not yet understood. While reduced disease activity has been described in intestinal symptoms due to its potentially positive e ects on the intestinal barrier, there are negative reports on the e cacy of cromoglycate acid in the skin and extraintestinal manifestations. -At present, there are no randomized treatment studies on budesonide in IgE-mediated food allergy. Existing recommendations are based on case and expert reports, and the extrapolation of data to patients with eosinophilic disease of which 50 % are associated with IgE-mediated allergy [85, 86, 87] . e above-mentioned treatment options using mast cell stabilizers and budesonide can be considered on an individual basis in the case of gastrointestinal symptoms alone. ey should be critically reviewed, primarily by gastroenterologists, in terms of their e cacy.
Recommendations
Acute treatment
Patients at risk of severe reactions should be equipped with emergency medication, including an adrenaline autoinjector strong consensus
Severe allergic reactions to food should be treated with intramuscularly administered adrenaline.
strong consensus
Antihistamines can be used in acute non-lifethreatening symptoms, most notably to treat urticarial and mucosal reactions.
The prophylactic use of antihistamines is not be recommended.
consensus
Long-term treatment
Since cromoglycate acid and ketotifen exhibited no treatment effect when all patient cohorts were taken into consideration, it is currently not possible to make a standard treatment recommendation for all patient groups. Gastrointestinal symptoms require individual treatment decision-making and monitoring. Guideline Guidelines on the management of IgE-mediated food allergies
Long-term management of food allergy
How does one implement avoidance measures in everyday life?
Dietary treatment and allergen labeling
Long-term food allergy management includes: -Avoidance of relevant foods -Substitution with suitable foods -e implementation of treatment measures in everyday life [4] . Avoidance is the most important intervention to prevent the onset of symptoms. Since, for ethical reasons, randomized controlled studies in non-food-allergic individuals, or in food-allergic individuals from whom dietary treatment is withheld in the control group, are critically viewed, valid data on the e ciency of avoidance measures are not available.
However, this lack of consistent data on the ecacy of avoidance [88, 89, 90, 91] can not be interpreted as evidence that elimination diets are ineffective.
erapeutic elimination diets are tailored to the individual allergy and nutritional requirements of the a ected individual. e requirements, aims, and expected results of dietary therapy vary considerably according to age and elicitating or causing allergen pro le (primary vs. secondary food allergy).
Ideally, a ected individuals receive treatment advice from a dietician with allergological experience. Individual tolerance to the eliciting food can vary between allergic individuals and may change on an individual basis. is applies to primary but also secondary food allergies. For dietary therapy it is important to take into consideration the aug- CI, confidence interval mentation factors for allergic reactions discussed in Sect. 4.1, "Patient history and diet/symptom protocols."
Cow's milk substitution
Cow's milk allergy with the onset before the age of 1 year requires special dietary treatment ( extensively hydrolyzed amino acid-based formula) in order to ensure that infants grow and thrive in an age-appropriate manner. However, in such cases, the only means of providing an infant with su cient nutrients is mainly via bottle-feeding. e speci c formula to be used is selected on a case-by-case basis: An extensive hydrolysate is generally the formula of rst choice. Amino acid-based formulas can be bene cial in those a ected by severe (notably also gastrointestinal) symptoms [90, 92, 93, 94, 95] .
Soy formulas are not be recommended in infants aged under 12 months. Moreover, feeding with soy products in the rst year of life is viewed critically due to their possible phytoestrogen, phytate and aluminum content. is is particularly relevant in the case of high intake per kilogram bodyweight, i. e., up to the age of 6 months. e risk:bene t ratio of soy formula in a predominantly milk substitutebased diet with low quantities of other foods is unfavorable.
Like sheep and goat milk, partially hydrolyzed infant formulas are not well suited for the treatment of cow's milk allergy [97, 98] .
Food avoidance during breastfeeding
If a breastfed infant is a ected by symptoms caused by the mother's intake of certain foodstu s, the breastfeeding mother should eliminate the suspected triggering food(s) from her diet followed by dietary counseling. Mothers should receive dietary advice if milk and milk products need to be eliminated on a long-term basis. Supplements are required in cases where it is not possible to achieve su cient intake, e. g. calcium.
Monitoring and re-evaluating clinical relevance
Extensive and long-term avoidance measures need to be monitored carefully. ey may cause: -Insu cient nutritional intake -Impaired quality of life us, counseling on dietary intake should include the calculation and possibly optimization of nutritional values to ensure a balanced and age-appropriate diet.
In order to ensure that avoidance measures are not maintained for longer than necessary, it is important to regularly review their clinical relevance. Cow's milk or hen's egg allergy should be re-evaluated by means of challenge testing at 6-to 12-month intervals in young children and 12-to 18-month intervals in older children.
e re-evaluation of prognostically unfavorable allergies, e. g. caused by nuts or peanuts, should be made on a case-by-case basis. Primarily such cases should be considered where no accidental allergic reactions have occurred. A follow-up patient history should be taken in case of pollenassociated food allergies to compile an accurate record of clinically relevant cross reactions over time.
Patient instruction and allergen labeling
Patient training is considered a key instrument of dietary intervention to achieve long-term elimination in everyday life. Training programs are designed to teach patients, their families, relatives and caregivers -to be aware of and to identify risk situations -to be able to read lists of ingredients -to completely avoid relevant triggers (in and outside the home (e. g., in restaurants)) Patients should be informed about the European Food Information Regulation (EU FIR): 1. e EU FIR requires that the 14 most important triggers of allergies and non-allergic intolerance need to be declared if they, or their associated products, have been included as an ingredient in a food (i. e., knowingly and as part of a recipe). ese are the following: -Gluten-containing cereal: wheat (spelt, khorasan wheat), rye, barley, oats -Crustaceans, egg, sh, peanuts, soybeans, milk -Nuts: almonds, hazelnuts, walnuts, cashew nuts, pistachio nuts, pecan nuts, Brazil nuts, macadamia (Queensland) nuts -Celery, mustard, sesame seeds, lupine, and mollusks -sul tes Mandatory labeling applies to pre-packaged as well as non-pre-packaged foods. 2. There is no legal framework governing the labeling of allergens that occur unintentionally in packaged or loose products. Trace allergen labeling, which is voluntary, is not able to provide information at the level (allergen amount) of contamination or its true likelihood due to the lack of limit values, nor does its absence signify per se that a food is safe. Thus, it should always be interpreted on an individual basis. Patients, their families, relatives and caregivers should be given the following informations: -Substitute products -Recipes to prepare their usual and preferred meals despite avoidance
Therapeutic use of pro-and prebiotics
Due to a lack of data the use of pre-and probiotics in the treatment of food allergy is not recommended.
Recommendations
An appropriate elimination diet is the keystone of food allergy management.
strong consensus
An elimination diet should be based on sound allergy diagnostic methods. Regular reviews regarding the indication are reqiuired. 
Gaps and important areas of research with regard to long-term management
-Long-term e ect of elimination diets on nutrition and quality of life -E ect of altered allergens (cooked milk/egg) on tolerance development -Long-term drawbacks of rice-and soy-based formulas in terms of a balanced diet -Strain-speci c (relating to certain micro-organisms) e ects on food allergy management using probiotics -Determination of allergen-speci c threshold values. Objective: To protect food-allergic individuals from severe reactions and to optimize food labeling in terms of ingredient and trace allergen labeling (unintended cross contact).
Reese, Schnadt, Schäfer, Fuchs
Immunotherapy in food allergy
Is it possible to perform e ective immunotherapy in food-allergy patients?
The use of allergen-speci c immunotherapy (AIT) in food allergy
Numerous attempts have been made to treat primary food allergy with: -subcutaneous (SCIT), -sublingual (SLIT) or -oral (OIT) allergen-speci c immunotherapy using foods or food extracts. Primary sensitizing pollen extracts have been used sublingually and subcutaneously to treat pollen-associated food allergy; in addition, oral and sublingual application of the food has also been investigated.
The use of SCIT in food allergy
Two studies showed evidence that treatment with verum is superior compared with placebo in SCIT using food allergen extracts for primary food allergy [100, 101] . Four other studies made similar observations on the e cacy of subcutaneously applied pollen allergens on pollen-associated food allergy [102, 103, 104, 105] . ese studies investigated the e ect of SCIT on birch-associated apple/ hazelnut allergy. A randomized study found no e ect for birch SCIT on birch-associated hazelnut allergy [106] .
The use of SLIT in food allergy
SLIT with food allergens, as investigated in four randomized studies, improved tolerance and reduced allergic symptoms to peanut, hazelnut, and peach [107, 108, 109, 110] . No improvement was seen in apple-allergic subjects in a randomized study using birch-pollen allergens [111] .
The use of OIT in food allergy
OIT using a wide variety of food allergens improved clinical tolerance in children and adults. is was shown in a number of randomized and non-randomized controlled studies -primarily with cow's milk, hen's egg, and peanut [112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128] -as well as in systematic reviews based partially on these studies [129, 130, 131, 132, 133] . However, (mostly mild but in rare case also severe) side e ects were observed in many patients undergoing OIT with allergens. A randomized study showed OIT with cow's milk or hen's egg to be not more e ective than elimination dieting in terms of tolerance development; however, these studies were conducted in young children [134] . Although a further study showed OIT to be more e ective in cow's milk allergy when compared directly with SLIT, it also caused more side e ects [116] . One study showed that the regular consumption of apples in birch-associated food allergy resulted in tolerance [135] .
While results for OIT appear to be promising the evidence is overall poor. us, OIT should be used only in controlled clinical studies [77] . ere are no data on long-term e ects yet. Due to con icting data on e cacy, subcutaneous and sublingual immunotherapy with pollen allergens should only be used in pollen-associated food allergy provided the primary inhalation allergy also requires treatment [3] .
Recommendations Primary food allergy
At present, specific oral, sublingual, or subcutaneous immunotherapy with food allergens should only be used in primary food allergy in the context of controlled studies.
strong consensus
Pollen-associated food allergy
Pollen-associated food allergy should only be treated with subcutaneous or sublingual immunotherapy using pollen allergens in the case of concomitant pollen-related respiratory symptoms. 
5.5.2.
Emergency plan e emergency plan should take into consideration all the possible variables that could impact the identi cation and treatment of allergic reactions to food, including:
-Patient age -Patient/family education level -Type and extent of the food allergy -Comorbidities -Place of residence and access to medical assistance e procedure management and in particular what should be done in the case of speci c symptoms, should be easy to understand to a non-informed third party.
Instruction and anaphylaxis training
Training should include the following aspects: -Patient-speci c avoidance strategies at home and in their social environment -Recognizing and interpreting warning signals -When and how allergic reactions need to be treated -When and how to use an adrenaline autoinjector
Who requires instruction?
Individuals professionally confronted with anaphylaxis patients should be considered in instruction programs. ese include: -general practitioners and pediatricians -dieticians -kitchen personnel -teachers and caregivers -rst aiders in companies Together, a multidisciplinary approach and the availability of written or online information on food allergies clearly improve knowledge and promote the correct use of adrenaline autoinjectors, thereby contributing to the reduction of allergic reactions [136] . In addition to direct family members other persons with whom the allergy su erer comes into close contact in their social environment should also be informed e. g., childcare center, school or workplace, ight personnel etc..
Patient organizations
Referring patients to relevant patient organizations, such as the German Allergy and Asthma Association (Deutsche Allergie-und Asthmabund, DAAB; www.daab.de) for questions regarding everyday management is helpful. A standardized training program ("AGATE," Arbeitsgemeinscha Anaphylaxie -Training und Edukation, "German working group on anaphylaxis training and education"; www.anaphylaxieschulung.de) is available in Germany for severe allergic reactions (anaphylaxis).
Recommendations
Patients, their relatives and caregivers should be informed about the foods to be avoided and practical information on avoidance measures, the recognition and self-management of future reactions should be given strong consensus
The option to contact a patient organization should be communicated to patients. 
Current developments in the diagnosis and treatment of food allergies
What new diagnostic and therapeutic methods are currently under development? 6.1. Diagnostic methods Molecular (synonym: component-based) diagnostic tests can determine speci c IgE antibodies to single food allergens. is approach improves both the test sensitivity and the diagnostic sensitivity of in vitro tests, their analytical speci city, and (in a small number of food analyses) also their diagnostic speci city: -Determining speci c IgE to the major allergen Ara h 2 in peanut allergy increases diagnostic speci city to between 72% and 96% [137, 138, 139, 140] . -An Ara h 2 greater than 40 kU/l yields a 95 % likelihood of a positive oral challenge in children with peanut allergy. -ω-5-Gliadin-speci c IgE is of high diagnostic relevance in exercise-induced food allergy to wheat [141] . -Speci c IgE to rGly m 4 in soy milk allergy in birch pollen-sensitized patients considerably increases test sensitivity (lower LoQ) and diagnostic sensitivity compared with extract-based diagnostic methods. Reagents for molecular diagnostic methods are available for certain fruits (apple, peach, and kiwi), hazelnut and peanut, soy, sh, and molluscs to detect speci c sensitization pro les. Further studies are needed to con rm the clinical usefulness of molecular-based IgE diagnostics. At present, whilst the determination of IgE to single allergens can contribute to risk assessment, it can not substitute placebo-controlled challenge testing.
Small clinical studies have investigated basophil activation assays for the diagnosis of cow's milk, hen's egg, and peanut allergy [140, 142, 143] and for the diagnosis of pollen-associated food allergy [144, 145, 146] . e basophil activation test (BAT), which generally shows exceptional analytical sensitivity, has greater diagnostic speci city and a better negative predictive value compared with skin testing and speci c IgE without in uencing the diagnostic sensitivity or the positive predictive value. Since the BAT requires a special laboratory setting and since large clinical studies on diagnostic sensitivity and speci city in the area of food allergy are lacking, this test is and will continue to be recommended primarily for research in food allergy.
Novel diagnostic options are emerging with the determination of speci c IgE against overlapping synthetic linear peptides. Although this approach has been described to date for milk [147, 148, 149] , peanut [150, 151] , egg [152] , shrimp [153, 154] , and celery [155] , there are currently no peptide-based tests available on the market that can currently be recommended for routine practice.
Treatment
Speci c immunotherapy approved for the treatment of food allergy is currently not available (see Sect. 5.3.2). Independent of oral and sublingual immunotherapeutic approaches [156] , the e cacy and tolerability of epicutaneous allergen immunotherapy in peanut allergy is currently being investigated in a multicenter study [157, 158] .
Food allergies are generally IgE mediated and attempts were performed to establish anti-IgE therapy to prevent the onset of symptoms. Despite promising results [159] , this approach has not pursued further for the time being. Recently a combined approach (anti-IgE antibodies plus OIT) was investigated in peanut-allergic patients [160] and suggested promising results. Considering such positive reports and studies in the literature, one should assess on an individual basis whether anti-IgE treatment is an option in patients with IgE-dependent severe repetitive life-threatening food allergic reactions. 
Epidemiology and triggers
IgE-sensitization to food allergens in an occupational setting can be acquired via the skin or the respira tory tract. Manifestations mainly occur in, but can also develop outside the workplace in form of [3] : -(Occupational) allergic rhinopathy and/or allergic asthma -Contact urticaria (CU) and/or protein contact dermatitis (PCD) (predominantly on the hands) [161, 162] Although CU and PCD to food allergens are extremely rare in the general population, their prevalence is signi cantly higher (1.5 %-20 %) in the food-processing industry depending on the occupation and cohort studied [161, 163, 164] . e prevalence of occupational asthmatic diseases in exposed employees ranges between 1 % and 20 % and is particularly high among bakers [165, 166, 167] . Flour allergy to wheat and rye is the most frequent cause of occupational allergic obstructive airway disease in Germany [166, 167] .
Food allergens from a wide variety of allergen sources have been described as triggers [161, 167, 168, 169] . Asthmatic bakers sensitized following inhalation exposure to wheat our exhibit other allergen pro les compared with individuals to orally acquired wheat-induced food allergy [166, 167] . In how far certain food allergens are able to trigger speci c allergic symptoms depending on the exposure route (oral, inhalant, or cutaneous) (Tab. 18) has not been clari ed for most allergen sources until to date [166, 170] .
Prevention
It is essential to protect employees from allergen exposure and sensitization by minimizing occupational health risks [167, 178] . Extensive occupational dermatological and occupational medicine guidelines and recommendations are available. In order to optimize preventive measures, the relevant insurance should be informed even if a possible occupational disease is suspected: -Dermatological report (Hautarztbericht) in the case of skin manifestations -Occupational disease noti cation in the case of airway symptoms
Symptoms and di erential diagnosis
Occupational skin disorders of varying origin on the hands are common in the food-processing industry, whereby eczematous skin disorders predominate. Hand eczema can be of irritant, allergic and endogenous origin. Speci c occupational and non-occupational triggers need to be investigated in the patient history and by means of patch testing [3, 163, 178] . Guideline Guidelines on the management of IgE-mediated food allergies IgE-mediated contact urticaria to food allergens is to be distinguished from non-immunological contact urticaria (e.g., elicited by benzoic acid, sodium benzoate, sorbic acid, abietic acid, nicotinic acid ester, cinnamic acid, cinnaminic aldehyde, balsam of Peru) [163] . e latter generally remains restricted to the area of contact, while IgE-mediated contact urticaria may cause systemic manifestations [184] . Non-occupational forms of urticaria should be considered in the di erential diagnosis [184] .
Diagnostic
In the case of suspected IgE-mediated allergic diseases related to the workplace, in particular work-related rhinopathy/asthma, the diagnostic process should be initiated early on, when the patient has not yet le the workplace [165] .
Stepwise diagnosis includes history-taking, skin prick testing (additional epicutaneous testing in PCD), speci c IgE determination and challenge testing [161, 162, 167, 171, 180, 181] . In vivo and in vitro diagnosis are challenging, because the extracts for occupationally relevant food allergens are o en lacking relevant allergens or are insu ciently standardized. e diagnostic sensitivity and speci city may vary considerably with the currently available occupational allergens depending on the allergen source and test solution [182, 185] . For the time being, parallel testing of skin prick test solutions from di erent manufacturers is recommended [182] . To detect CU and PCD against food allergens, skin prick tests should be performed with fresh material [161, 186] .
Skin prick tests to diagnose occupational type-1 allergies should be performed using a metal lancet if possible using double determinations. Where reproducible, wheals of even small diameters (≥ 1.5 mm) when controls are negative should be considered as positive and con rmed serologically [182] . Medically monitored allergen avoidance and re-exposure, as well as workplace-related challenge testing may be required to establish the diagnosis. e speci c inhalation challenge test is considered the gold standard for many triggers of occupational allergy. However, a negative result in this test or following exposure at the workplace is not su cient to exclude the diagnosis of occupational asthma in the presence of otherwise good evidence [165, 167, 180] . Further diagnostic measures are given in "Prevention of occupational obstructive airway disease" guidelines [165, 180] .
Course and treatment
E orts should be made to achieve early allergen avoidance in occupational IgE-mediated allergies in order to avoid symptom exacerbation and the onset of OD 5101 (in the case of allergic skin disorders) or OD 4301 (in the case of allergic airway symptoms) [165, 179, 187] . Treatment measures as well as the bene ts of various management options for occupational allergic rhinopathy and obstructive airway disease are discussed in the "Prevention of occupational obstructive airway disease" guidelines [165] . Although allergen avoidance by avoiding exposure or by using suitable protective gear can result in the improvement or resolution of IgE-mediated skin disorders caused by food allergens, these measures are not always successful [162] . In the food-processing industry, individuals a ected by PCD exhibit a more severe course and have a less favorable prognosis compared with patients with skin disorders of the hands of other origin. Signi cant di erences were seen in terms of: -e need to consistently wear protective gloves at work -e duration of absence to work -e frequency of occupational changes [164] In cases where it is not possible to achieve a symptom control with allergen avoidance or a reduced exposure by means of technical/organizational measures or the use of personal protective gear, individuals affected by occupationally acquired IgE-mediated food allergy may be forced on objective grounds to cease the relevant occupation. When assessing reduced capacity to work, it is important to take into consideration not only the severity of clinical disorders [183] , but also the proportion of jobs on the general labor market precluded due to allergy [179, 187] .
It is possible for food allergens to elicit concomitant occupational skin and airway symptoms. Since this represents a uniform allergic disease involving symptoms in various organs, this particular constellation should be treated as one insured lossbased on OD No. 5101 and OD No. 4301 -thereby necessitating an assessment of the overall reduction in capacity to work while taking the impact of the allergy into consideration [187, 188] .
Recommendations/core statements
The diagnostic work-up in suspected IgEmediated occupational allergic disease should be initiated promptly, assuming the patient has not yet left the job, in order to perform, e.g., workplace-related measurements and exposure challenge testing in addition to specific stepwise diagnostic tests.
strong consensus
Allergen avoidance has priority also in occupational food allergies using appropriate protective measures. Where this is not possible the need to cease the relevant occupation should be assessed.
Method report
Guidelines initiation and interest group participation e S2k-guideline "Management of IgE-mediated food allergies" [German Association of Scienti c Medical Societies (Arbeitsgemeinscha der Wissenscha lichen Medizinischen Fachgesellscha ) register number 061-031] was initiated by the German Society for Allergology and Clinical Immunology (Deutsche Gesellscha für Allergologie und Klinische Immunologie, DGAKI). Prof. Dr. med. Margitta Worm, from the Charité Allergy Center, was responsible for coordinating the guidelines project. e Division of Evidence Based Medicine (dEBM), PD Dr. med. Alexander Nast, provided methodological supervision.
In all, 15 specialist societies, professional associations, and other organizations participated in the preparation of the guideline and nominated o cial representatives for the guideline group (Tab. 19).
e German Allergy and Asthma Association (Deutsche Allergie-und Asthmabund) represented patient interests.
Formulation of the recommendations and structured consensus-nding
Dra s of the text and recommendations in the guidelines sections were elaborated by the authors and then submitted via email to the guidelines group. A distinction was made in the derivation of the guidelines between three levels of recommendation that express the strength of recommendation (Tab. 1).
Consensus was reached on the proposed recommendations and core statements using a nominal group technique during two consensus conferences held on 11 April 2014 and 4 July 2014 in Berlin, Germany. PD Dr. med. Alexander Nast (AWMF guideline advisor) acted as facilitator of the structured consensus-nding process. Once the recommendations Guideline Guidelines on the management of IgE-mediated food allergies on which consensus was sought had been presented, each group member was invited to share their comments on the dra . Divergent proposals were noted. is was followed by: a discussion of each point, a preliminary vote, debating/discussion, and a nal vote. Each member of the expert group had one vote. Strong consensus (> 95 % agreement) was generally sought. Where this could not be reached despite discussion, recommendations were approved by consensus (> 75 % agreement). For one recommendation, it was possible to reach only a "majority approval" (50 %-74 % agreement). e respective strengths of consensus were documented. A Delphi procedure was conducted for those recommendations or core statements for which no consensus could be reached during the consensus conference.
Approval by the board members of participating organizations e guidelines manuscript was sent to the board members of all participating specialist societies, professional associations, and patient organizations on 27 March 2015 for their information and with the request for formal approval.
e approval process took place between 27 March 2015 and 28 May 2015.
Financing of the guidelines
e travel expenses of participating DGAKI members, as well as hospitality costs during the consensus meeting and facilitator costs totaling 10,000 Euro (to the Charité, Working Group of PD Dr. med. Alexander Nast) were borne by the DGAKI.
Disclosure and handling of con icts of interest
In order to disclose potential con icts of interest, all members of the guidelines group completed the "declaration of con icts of interest" form. Declarations were presented during the consensus conference and discussed. No signi cant con icts of interest were identi ed.
A summary of con icts of interest declarations is available on the AWMF website under http://www. awmf.org/leitlinien/detail/061-031.html.
